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Transmission of extracellular signals into
the cell often relies on the binding of
extracellular signaling molecules to mem-
brane receptors. How membrane recep-
tors transmit these signals into the cell
and activate intracellular signaling cascades
has been an intense field of research over
the last 20 years. Basically, two compet-
ing models have been proposed. In the
first model, binding of signaling mole-
cules promotes ligand-induced dimeriza-
tion/oligomerization of receptors. Accord-
ing to the second model, binding of sig-
naling molecules triggers ligand-induced
conformational changes within preformed
dimeric/oligomeric receptors.
For many years, the model of ligand-
induced dimerization was the preferred
model to explain the activation of many
single transmembrane-spanning receptors
that rely on the (trans)phosphorylation of
their intracellular domains. One of these
receptors is the prolactin receptor (PRLR),
which belongs to the cytokine receptor
family that is devoid of intrinsic kinase
activity but constitutively interacts with
the JAK2 tyrosine kinase. PRLR activa-
tion triggers first trans-phosphorylation
of two JAK2 molecules (each bound to
one PRLR molecule), followed by receptor
phosphorylation by JAK2 and recruitment
of STAT5 molecules promoting further
downstream signaling events.
Before the publication of the article of
Tallet et al. in Frontiers in Endocrinology (1),
conflicting results had been reported in the
literature concerning the activation model
of the PRLR. Indeed, Qazi et al., using
bioluminescence resonance energy transfer
(BRET) and co-immunoprecipitation (co-
IP) approaches, concluded that the PRLR
constitutively homodimerize (or het-
erodimerized when long and short iso-
forms were co-expressed in the same cell)
(2). A similar conclusion was reached
in another study based on co-IP exper-
iments further arguing for the existence
of ligand-independent homodimers of
human PRLR isoforms, with the trans-
membrane domain being the main dimer
interface (3). Contrasting results were how-
ever reported in another BRET study
with various C-terminally tagged PRLR
isoforms. The authors revealed ligand-
dependent changes in BRET signals that
discriminated receptor agonists from a par-
tial agonist/antagonist (4). Unfortunately,
the authors did not perform complemen-
tary experiments to determine whether
the BRET changes originated from ligand-
induced dimerization or conformational
changes as previously reported for other
cytokine receptors (5).
The article of Tallet et al. published in
Frontiers in Endocrinology made a decisive
contribution because the authors recapit-
ulated all previously employed techniques
(co-IP, BRET) in a single study and went
beyond the current status by exploiting
further techniques such as blue native
gel electrophoreses and time-resolved flu-
orescence resonance energy transfer (TR-
FRET). This presents the first application
of the TR-FRET technology to cytokine
receptors. TR-FRET is based on the energy
transfer between the energy donor ter-
bium cryptate (Tb) and an energy acceptor.
Due to the long-lived fluorescence proper-
ties of Tb, measurement can be performed
after a time delay of 50–150µs to avoid
interference with cellular autofluorescence,
thereby considerably improving the signal-
to-noise ratio of the assay (6). TR-FRET
has several interesting features that differ-
entiate this technique from BRET. Whereas
BRET signals typically represent all tagged
proteins that interact, irrespective of their
subcellular localization, TR-FRET signals
are only generated by the fraction of pro-
teins located at the plasma membrane.
This difference seems to be important as
the PRLR is mainly located inside the cell
and only the fraction that reaches the cell
surface becomes activated by the extra-
cellular prolactin. Furthermore, the inten-
sity of TR-FRET signals directly correlates
with the distance between the donor and
acceptor, which allows us to be conclu-
sive regarding this parameter. This is more
difficult to achieve with the BRET tech-
nique as BRET signals depend not only on
the distance but also on the relative ori-
entation of the BRET donor and acceptor.
In the study of Tallet et al., the authors
designed a TR-FRET assay to monitor
putative ligand-induced TR-FRET signal
changes between two extracellular PRLR
domains. Taken all techniques together, the
authors convincingly demonstrated that
(at least part of) the PRLR population
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is pre-dimerized at the cell membrane
and that activation (via ligand binding or
I146L mutation that constitutively activates
the receptor) or inactivation (by receptor
antagonists) do not alter the number of
dimers or the distance between the two
extracellular domains of PRLR dimers, sug-
gesting that the control of receptor activity
involves subtle conformational changes.
A subsequent study that solved the
nuclear magnetic resonance solution struc-
ture of the membrane proximal D2 domain
of the human PRLR (7), confirmed this
conclusion as the authors showed that the
conserved WSXWS motif of the D2 domain
undergoes conformational changes upon
ligand binding (from a T-stack to a lad-
der) which serves as a molecular switch for
activation. Consistently, the constitutively
active PRLR-I146L showed a change in the
dynamic of this motif.
The article of Tallet et al. had an impor-
tant impact in its field as it allowed to
exclude one hypothesis and definitely
oriented the search for intramolecular
conformational changes without impact on
receptor stoichiometry or major changes in
the distance of the extracellular domains.
Future work will now fully concentrate
on the mechanism of PRLR activation
involving intramolecular conformational
changes. Recent advances on the activation
mechanism of other cytokine receptors
such as the growth hormone receptor
(GHR) appear to consolidate the proposed
PRLR activation model and is likely to
provide additional insights (8). Accord-
ing to the current model, GHR exists as
preformed inactive dimer in which the
two subunits are held together through
weak interactions in the transmembrane
domain. Receptor dimers are proposed
to associate with a JAK2 dimer through
the Box 1 motif in the intracellular region
of the receptor in a way that the kinase
domain of one JAK2 molecule binds to the
pseudokinase domain of the other JAK2
molecule in “trans,” thus inhibiting kinase
activity in the basal state. Binding of growth
hormone to GHR alters the position of the
extracellular juxtamembrane, transmem-
brane, and intracellular domain of the
GHR in an outward movement align-
ing and activating the two JAK2 kinase
domains. Future studies will show whether
PRLR activation fits to this model. Such
a mechanism opens also new therapeutic
routes. For example, antibodies directed
against the extracellular juxtamembrane
domain might stabilize the active confor-
mation of the receptor or disruption of
the JAK2 kinase/pseudokinase interaction
with small molecules might help to activate
the kinase.
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